en

PRODUCT DETAIL

Leuprorelin Sandoz 5 mg implantát

Code 80454
MA number 56/0564/09-S
Product Form: imp 3x5 mg (striek.inj.napl.plast.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02A HORMONES AND RELATED AGENTS
L02AE Gonadotropin releasing hormone analogues
L02AE02 Leuprorelin
Shelf life: 48
Container: pre-filled syringe PP
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 25.09.2009
SPC: SPC_Leuprorelin_5mg_08_2022.pdf  
PIL: PIL_Leuprorelin_02_2023.pdf  
Safety feature Yes
Data update: 29.05.2018
eu-flag.png sk-flag.png